Cognitive Muscular Therapy for Patients With Long-COVID and Breathing Pattern Disorder (NCT06503913) | Clinical Trial Compass
CompletedNot Applicable
Cognitive Muscular Therapy for Patients With Long-COVID and Breathing Pattern Disorder
United Kingdom18 participantsStarted 2024-08-01
Plain-language summary
The aim of the study is to test a treatment known as "Cognitive Muscular Therapy (CMT)" for reducing breathlessness and improving autonomic function in patients with long-COVID.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Above 18 years old
* Experience moderate/severe breathlessness, quantified using the Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) scale.
* Speak and understand English sufficiently to read the information sheet and sign the consent form
* Ability to stand without any assistive device for at least 20 minutes (to ensure sufficient capacity to complete the intervention)
Exclusion Criteria:
* Dementia or other major cognitive impairment
* BMI \>32 (as increased subcutaneous fat prevents use of breathing measurement system)
* Current smoker or smoked regularly within last 6 months
* Any cardiorespiratory disease that requires medical intervention (except asthma management)
* Currently receiving physiotherapy-based treatment for LC or breathing pattern disorder
* Significant respiratory co-morbidity (e.g. COPD, uncontrolled Asthma)
What they're measuring
1
Change in Nijmegen Questionnaire
Timeframe: Change from Baseline to two months (post intervention) & change from Baseline to 5 months (post intervention)